FDA lifts drug supply chain security requirements for COVID-19 products

The US Food and Drug Administration (FDA) on Thursday issued guidance detailing exclusions and exemptions to certain requirements under the Drug Supply Chain Security Act triggered by the coronavirus disease (COVID-19) public health emergency.